Free tool
Drugs in development
Last checked: Nov 20, 2026Latest source record: rebuilt Nov 18, 2026Source: ClinicalTrials.govMethods & limitations
Drugs in development
3,685
Not FDA-approved
In Phase 3
1,424
Highest phase reached
Matching your filters
267
267 drugs in development
Names, sponsors and conditions come from the trial records. Click a drug for its trials.
- IanalumabVAY736, VAY736 AIPhase 318 trials
Novartis · Primary Immune Thrombocytopenia (ITP), Systemic Lupus Erythematosus, Sjogren Syndrome
- AK117Phase 314 trials
Akeso · Advanced Malignant Tumors, ACUTE MYELOID LEUKEMIA; AML, Higher-risk Myelodysplastic Syndromes
- BrenipatideLY3537031Phase 313 trials
Eli Lilly · Alcohol Use Disorder, Irritable Bowel Syndrome, Depressive Disorder, Major
- PovorcitinibINCB054707, INCB54707Phase 312 trials
Incyte · Hidradenitis Suppurativa (HS), NonSegmental Vitiligo, Prurigo Nodularis
- APG-2575lisaftoclaxPhase 310 trials
Ascentage Pharma Group Inc. · CLL/SLL, Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma
- AZD0120GC012FPhase 39 trials
AstraZeneca · Newly Diagnosed Multiple Myeloma (NDMM), Relapsed AL Amyloidosis, Refractory AL Amyloidosis
- EtentamigABBV-383, TNB-383BPhase 38 trials
AbbVie · Multiple Myeloma, Relapsed or Refractory Multiple Myeloma, Amyloid Light Chain (AL) Amyloidosis
- CM336group, QiShen YiQi Dripping Pills 3 bagsPhase 37 trials
Keymed Biosciences Co.Ltd · Multiple Myeloma (MM), Primary Light-Chain Amyloidosis, Primary Immune Thrombocytopenia
- GlucocorticoidsPhase 37 trials
Novartis · VEXAS Syndrome, ANCA Associated Vasculitis (AAV), Anti-Glomerular Basement Membrane Disease
- IMVT-1402Phase 37 trials
Immunovant Sciences GmbH · Graves' Disease, Rheumatoid Arthritis, Subacute Cutaneous Lupus Erythematosus
- ObicetrapibPhase 37 trials
NewAmsterdam Pharma · Lipidemia, Preclinical Alzheimer's Disease, Antioxidant Absorption
- siRNAADX-038, ADX-324Phase 37 trials
ADARx Pharmaceuticals, Inc. · Hereditary Angioedema, HAE, Hereditary Angioedema - Type 1
- AND017Phase 36 trials
Kind Pharmaceuticals LLC · Anemia Due to Chronic Kidney Disease, β -Thalassemia, Cancer-Related Anemia
- ElriterceptTAK-226, KER-050Phase 36 trials
Takeda · Myelodysplastic Syndromes, Myelofibrosis, Anemia
- LUM-201Phase 36 trials
Lumos Pharma · Growth Hormone Deficiency, Growth Hormone Deficiency (GHD), Obesity & Overweight
- NizubaglustatAZ-3102Phase 36 trials
Azafaros B.V. · Niemann-Pick Type C Disease, GM2 Gangliosidosis, GM1 Gangliosidosis
- CRN04894AtumelnantPhase 35 trials
Crinetics Pharmaceuticals Inc. · Congenital Adrenal Hyperplasia, Classic Congenital Adrenal Hyperplasia, Cushing Syndrome
- DeucrictibantPHVS416, PHA121Phase 35 trials
Pharvaris Netherlands B.V. · Hereditary Angioedema (HAE), Hereditary Angioedema, Hereditary Angioedema Type I
- MibavademabREGN4461Phase 35 trials
Regeneron · Generalized Lipodystrophy, Functional Hypothalamic Amenorrhea, FHA
- NPI-001N-Acetylcysteine AmidePhase 35 trials
Nacuity Pharmaceuticals, Inc. · Retinitis Pigmentosa (RP), Usher Syndrome, Alzheimer´s Disease
- VenglustatGZ402671Phase 35 trials
Sanofi · Fabry Disease, Gaucher's Disease Type III, Gaucher Disease Type 1
- AlimatravirMK-8527Phase 34 trials
Merck & Co. · Human Immunodeficiency Virus (HIV), HIV Pre-Exposure Prophylaxis, HIV
- BPN14770zatolmilastPhase 34 trials
Tetra Discovery Partners · Fragile X Syndrome, Jordan's Syndrome, PPP2R5D Neurodevelopmental Disorder
- CamlipixantBLU-5937Phase 34 trials
GSK · Refractory Chronic Cough, Cough, Irritable Bowel Syndrome
- GlepaglutideZP1848Phase 34 trials
Zealand Pharma · Short Bowel Syndrome, Short Bowel Syndrome (SBS)
- InpegsomatropinPhase 34 trials
Xiamen Amoytop Biotech Co., Ltd. · Turner Syndrome, Idiopathic Short Stature, Adult Growth Hormone Deficiency
- JNT-517Phase 34 trials
Otsuka · Phenylketonuria (PKU), Phenylketonuria
- Kedrion IVIG 10%KIg 10, Immune globulin 10% for administrationPhase 34 trials
Kedrion S.p.A. · Primary Immunodeficiency Disease, Chronic Primary Immune Thrombocytopenia (ITP), Chronic Inflammatory Demyelinating Polyneuropathy
- LP352bexicaserinPhase 34 trials
Longboard Pharmaceuticals · Developmental and Epileptic Encephalopathy, Dravet Syndrome, Lennox-Gastaut Syndrome
- NTI164FEN164Phase 34 trials
Fenix Innovation Group · Rett Syndrome, Autism, Autism Spectrum Disorder
- SCTC21CPhase 34 trials
Sinocelltech Ltd. · IgA Nephropathy, Multiple Myeloma (MM), Systemic Lupus Erythematosus (SLE)
- SR604Phase 34 trials
Shanghai RAAS Blood Products Co., Ltd. · Factor VII Deficiency, Hemophilia A, Hemophilia B
- ACC017Phase 33 trials
Jiangsu Aidea Pharmaceutical Group Co., Ltd. · Infection, Human Immunodeficiency Virus
- ALK-001C20-D3-Retinyl Acetate, C20 Deuterated vitamin APhase 33 trials
Alkeus Pharmaceuticals, Inc. · Stargardt Disease, Stargardt Macular Degeneration, Stargardt Macular Dystrophy
- AOC 1044Phase 33 trials
Avidity Biosciences, Inc. · DMD, Duchenne Muscular Dystrophy, Exon 44
- BBP-418ribitolPhase 33 trials
ML Bio Solutions, Inc. · Limb-Girdle Muscular Dystrophy Type 2I (LGMD2I), LGMD2I
- DazodalibepVIB 4920, MEDI 4920Phase 33 trials
Amgen · Sjögren's Syndrome (SS), Sjögren's Syndrome, Sjogren's Syndrome
- Del-desiranAOC 1001Phase 33 trials
Avidity Biosciences, Inc. · DM1, Myotonic Dystrophy, Myotonic Dystrophy 1
- delpacibart braxlosiranAOC-1020, del-braxPhase 33 trials
Avidity Biosciences, Inc. · FSHD, FSHD1, FSHD2
- FazirsiranTAK-999, ARO-AATPhase 33 trials
Takeda · Alpha1-Antitrypsin Deficiency
- ICP-488Phase 33 trials
Beijing InnoCare Pharma Tech Co., Ltd. · Plaque Psoriasis Patients, Primary Sjögren's Syndrome, Cutaneous Lupus Erythematosus (CLE)
- KVD900Phase 33 trials
KalVista Pharmaceuticals, Ltd. · Hereditary Angioedema
- MilvexianJNJ-70033093, BMS-986177Phase 33 trials
Johnson & Johnson (Janssen) · Ischemic Stroke; Ischemic Attack, Transient, Atrial Fibrillation, Acute Coronary Syndrome
- obudanersenION582Phase 33 trials
Ionis Pharmaceuticals · Angelman Syndrome
- QRX003Phase 33 trials
Quoin Pharmaceuticals · Netherton Syndrome
- RO7204239Phase 33 trials
Roche (Genentech) · Obesity, Overweight, Overweight With One Weight Related Comorbidity
- ULOMK-8507, UlonivirinePhase 33 trials
Merck & Co. · Human Immunodeficiency Virus Type 1 (HIV-1) Infection, HIV-1 Infection
- 2 NRTIsPhase 32 trials
Merck & Co. · Human Immunodeficiency Virus (HIV) Infection, Infection, Human Immunodeficiency Virus, HIV Infections
- AAV2-hRPE65v2voretigene neparvovec-rzylPhase 32 trials
Roche (Genentech) · Leber Congenital Amaurosis, Inherited Retinal Dystrophy Due to RPE65 Mutations
- AcotiamideItopride HydrochloridePhase 32 trials
Getz Pharma · Postprandial Distress Syndrome, Functional Dyspepsia
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.